CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C17204 | BRD-K46393778 | BRD-K46393778 | -- | -- | -- | Details |
| C17205 | BRD-K46396728 | BRD-K46396728 | -- | -- | -- | Details |
| C17206 | BRD-K46400317 | BRD-K46400317 | -- | -- | -- | Details |
| C17207 | BRD-K46401069 | BRD-K46401069 | -- | -- | -- | Details |
| C17208 | BRD-K46407773 | BRD-K46407773 | -- | -- | -- | Details |
| C17209 | BRD-K46412655 | BRD-K46412655 | -- | -- | -- | Details |
| C17210 | BRD-K46413323 | BRD-K46413323 | -- | -- | -- | Details |
| C17211 | BRD-K46416377 | BRD-K46416377 | -- | -- | -- | Details |
| C17212 | BRD-K46419649 | U-0126 | MAP2K1; MAP2K2 | MEK inhibitor | -- | Details |
| C17213 | BRD-K46419847 | BRD-K46419847 | -- | -- | -- | Details |
| C17214 | BRD-K46424862 | hymecromone | MAOA; MAOB | Monoamine oxidase inhibitor | -- | Details |
| C17215 | BRD-K46428124 | BRD-K46428124 | -- | -- | -- | Details |
| C17216 | BRD-K46428287 | BRD-K46428287 | -- | -- | -- | Details |
| C17217 | BRD-K46429791 | BRD-K46429791 | -- | -- | -- | Details |
| C17218 | BRD-K46435528 | trichloroethylene | -- | -- | -- | Details |
| C17219 | BRD-K46435977 | valaciclovir | -- | -- | -- | Details |
| C17220 | BRD-K46439376 | BRD-K46439376 | -- | -- | -- | Details |
| C17221 | BRD-K46441700 | GR-55562 | HTR1B | Serotonin receptor antagonist | -- | Details |
| C17222 | BRD-K46445327 | BRD-K46445327 | -- | -- | -- | Details |
| C17223 | BRD-K46445956 | BRD-K46445956 | -- | -- | -- | Details |
| C17224 | BRD-K46446437 | BRD-K46446437 | -- | -- | -- | Details |
| C17225 | BRD-K46447740 | BRD-K46447740 | -- | -- | -- | Details |
| C17226 | BRD-K46448313 | BRD-K46448313 | -- | -- | -- | Details |
| C17227 | BRD-K46450665 | BRD-K46450665 | -- | -- | -- | Details |
| C17228 | BRD-K46458719 | BRD-K46458719 | -- | -- | -- | Details |
| C17229 | BRD-K46469693 | SCH-442416 | ADORA1; ADORA2A | Adenosine receptor antagonist | -- | Details |
| C17230 | BRD-K46473681 | BRD-K46473681 | -- | -- | -- | Details |
| C17231 | BRD-K46476470 | BRD-K46476470 | -- | -- | -- | Details |
| C17232 | BRD-K46476822 | BRD-K46476822 | -- | -- | -- | Details |
| C17233 | BRD-K46477974 | BRD-K46477974 | -- | -- | -- | Details |
| C17234 | BRD-K46489288 | BRD-K46489288 | -- | -- | -- | Details |
| C17235 | BRD-K46493214 | saccharin | -- | -- | -- | Details |
| C17236 | BRD-K46494135 | BRD-K46494135 | -- | -- | -- | Details |
| C17237 | BRD-K46496627 | BRD-K46496627 | -- | -- | -- | Details |
| C17238 | BRD-K46498981 | BRD-K46498981 | -- | -- | -- | Details |
| C17239 | BRD-K46499837 | BRD-K46499837 | -- | -- | -- | Details |
| C17240 | BRD-K46503544 | etoposide | TOP2A; TOP2B | Topoisomerase inhibitor | -- | Details |
| C17241 | BRD-K46504268 | BRD-K46504268 | -- | -- | -- | Details |
| C17242 | BRD-K46505016 | BRD-K46505016 | -- | -- | -- | Details |
| C17243 | BRD-K46512534 | BRD-K46512534 | -- | -- | -- | Details |
| C17244 | BRD-K46512834 | BRD-K46512834 | -- | -- | -- | Details |
| C17245 | BRD-K46522835 | BRD-K46522835 | -- | -- | -- | Details |
| C17246 | BRD-K46523383 | pramocaine | -- | -- | -- | Details |
| C17247 | BRD-K46525610 | BRD-K46525610 | -- | -- | -- | Details |
| C17248 | BRD-K46526566 | BRD-K46526566 | -- | -- | -- | Details |
| C17249 | BRD-K46531780 | methyl-benzethonium | -- | -- | -- | Details |
| C17250 | BRD-K46532897 | BRD-K46532897 | -- | -- | -- | Details |
| C17251 | BRD-K46532981 | BRD-K46532981 | -- | -- | -- | Details |
| C17252 | BRD-K46533463 | BRD-K46533463 | -- | -- | -- | Details |
| C17253 | BRD-K46544760 | BRD-K46544760 | -- | -- | -- | Details |
| C17254 | BRD-K46549154 | BRD-K46549154 | -- | -- | -- | Details |
| C17255 | BRD-K46555627 | BRD-K46555627 | -- | -- | -- | Details |
| C17256 | BRD-K46555875 | BRD-K46555875 | -- | -- | -- | Details |
| C17257 | BRD-K46556387 | BRD-K46556387 | -- | -- | -- | Details |
| C17258 | BRD-K46556543 | potassium-canrenoate | NR3C2 | Mineralocorticoid receptor antagonist | -- | Details |
| C17259 | BRD-K46558254 | BRD-K46558254 | -- | -- | -- | Details |
| C17260 | BRD-K46560430 | BRD-K46560430 | -- | -- | -- | Details |
| C17261 | BRD-K46561246 | BRD-K46561246 | -- | -- | -- | Details |
| C17262 | BRD-K46561506 | BRD-K46561506 | -- | -- | -- | Details |
| C17263 | BRD-K46562045 | BRD-K46562045 | -- | -- | -- | Details |
| C17264 | BRD-K46562329 | BRD-K46562329 | -- | -- | -- | Details |
| C17265 | BRD-K46574442 | BRD-K46574442 | -- | -- | -- | Details |
| C17266 | BRD-K46575753 | BRD-K46575753 | -- | -- | -- | Details |
| C17267 | BRD-K46580984 | phenserine | APP; ACHE; BCHE | Beta amyloid inhibitor; Acetylcholinesterase inhibitor | -- | Details |
| C17268 | BRD-K46585355 | acetylsalicylsalicylic-acid | -- | -- | -- | Details |
| C17269 | BRD-K46587586 | SA-1456508 | -- | -- | -- | Details |
| C17270 | BRD-K46588240 | BRD-K46588240 | -- | -- | -- | Details |
| C17271 | BRD-K46592487 | BRD-K46592487 | -- | -- | -- | Details |
| C17272 | BRD-K46593635 | BRD-K46593635 | -- | -- | -- | Details |
| C17273 | BRD-K46594703 | BRD-K46594703 | -- | -- | -- | Details |
| C17274 | BRD-K46597784 | BRD-K46597784 | -- | -- | -- | Details |
| C17275 | BRD-K46599299 | BRD-K46599299 | -- | -- | -- | Details |
| C17276 | BRD-K46599443 | BRD-K46599443 | -- | -- | -- | Details |
| C17277 | BRD-K46603043 | BRD-K46603043 | -- | -- | -- | Details |
| C17278 | BRD-K46604138 | dapagliflozin | SLC5A2 | Sodium/glucose cotransporter inhibitor | -- | Details |
| C17279 | BRD-K46604793 | BRD-K46604793 | -- | -- | -- | Details |
| C17280 | BRD-K46607226 | BRD-K46607226 | -- | -- | -- | Details |
| C17281 | BRD-K46609723 | BRD-K46609723 | -- | -- | -- | Details |
| C17282 | BRD-K46610687 | BRD-K46610687 | -- | -- | -- | Details |
| C17283 | BRD-K46619710 | BRD-K46619710 | -- | -- | -- | Details |
| C17284 | BRD-K46620987 | BRD-K46620987 | -- | -- | -- | Details |
| C17285 | BRD-K46622484 | BRD-K46622484 | -- | -- | -- | Details |
| C17286 | BRD-K46623934 | BRD-K46623934 | -- | -- | -- | Details |
| C17287 | BRD-K46625537 | BRD-K46625537 | -- | -- | -- | Details |
| C17288 | BRD-K46625679 | MW-STK33-97 | -- | -- | -- | Details |
| C17289 | BRD-K46629170 | BRD-K46629170 | -- | -- | -- | Details |
| C17290 | BRD-K46639367 | BRD-K46639367 | -- | -- | -- | Details |
| C17291 | BRD-K46641047 | BRD-K46641047 | -- | -- | -- | Details |
| C17292 | BRD-K46643133 | BRD-K46643133 | -- | -- | -- | Details |
| C17293 | BRD-K46645809 | BRD-K46645809 | -- | -- | -- | Details |
| C17294 | BRD-K46652470 | nizatidine | HRH2 | Histamine receptor antagonist | -- | Details |
| C17295 | BRD-K46653995 | BRD-K46653995 | -- | -- | -- | Details |
| C17296 | BRD-K46654563 | zofenopril-calcium | ACE | Angiotensin converting enzyme inhibitor | -- | Details |
| C17297 | BRD-K46655163 | BRD-K46655163 | -- | -- | -- | Details |
| C17298 | BRD-K46658587 | BRD-K46658587 | -- | -- | -- | Details |
| C17299 | BRD-K46661156 | BRD-K46661156 | -- | -- | -- | Details |
| C17300 | BRD-K46663433 | BRD-K46663433 | -- | -- | -- | Details |
| C17301 | BRD-K46664882 | BRD-K46664882 | -- | -- | -- | Details |
| C17302 | BRD-K46666779 | BRD-K46666779 | -- | -- | -- | Details |
| C17303 | BRD-K46670060 | BRD-K46670060 | -- | -- | -- | Details |